Imodium multi-symptom relief and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium multi-symptom relief (loperamide hydrochloride; simethicone) and Lopressor (metoprolol tartrate). Common drug interactions include drug ineffective among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium multi-symptom relief and Lopressor. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium multi-symptom relief?

Imodium multi-symptom relief has active ingredients of loperamide hydrochloride; simethicone. It is often used in diarrhea. eHealthMe is studying from 5,486 Imodium multi-symptom relief users. Check the latest studies of Imodium multi-symptom relief.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.



On Aug, 05, 2026

12 people who take Imodium multi-symptom relief and Lopressor together, and have interactions are studied.

Imodium multi-symptom relief and Lopressor drug interactions.

What are the common drug interactions of Imodium Multi-Symptom Relief and Lopressor, by gender? *:

female:

  1. Drug ineffective
  2. Oropharyngeal pain
  3. Throat irritation
  4. Pneumonia

male:

  1. Abdominal pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Asthenia (weakness)
  4. Bacteraemia (presence of bacteria in the blood)
  5. Blood pressure systolic increased
  6. Burkholderia cepacia complex infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics)
  7. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  8. Chest pain
  9. Cholecystitis (infection of gallbladder)
  10. Chorea (abnormal involuntary movement disorder)

What are the common drug interactions of Imodium Multi-Symptom Relief and Lopressor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Bacteraemia (presence of bacteria in the blood)
  3. Burkholderia cepacia complex infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics)
  4. Cholecystitis (infection of gallbladder)
  5. Death
  6. Dyspnoea (difficult or laboured respiration)
  7. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  8. Liver injury
  9. Nausea (feeling of having an urge to vomit)
  10. Pancreatitis (inflammation of pancreas)

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Anaphylactic reaction (serious allergic reaction)
  3. Asthenia (weakness)
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chest pain
  6. Dyspnoea (difficult or laboured respiration)
  7. Erythema (redness of the skin)
  8. Headache (pain in head)
  9. Hypotension (abnormally low blood pressure)
  10. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Drug ineffective
  2. Oropharyngeal pain
  3. Emotional disorder
  4. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  5. Gastroenteritis (inflammation of stomach and intestine)
  6. Gout (uric acid crystals building up in the body)
  7. Hypotension (abnormally low blood pressure)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

  1. Pain: 3 people, 25.00%
  2. Stress And Anxiety: 2 people, 16.67%
  3. Irritable Bowel Syndrome: 1 person, 8.33%
  4. Depression: 1 person, 8.33%
  5. Diabetes: 1 person, 8.33%
  6. Diabetic Gastropathy (gastric neuromuscular dysfunction in diabetes mellitus): 1 person, 8.33%
  7. Gout (uric acid crystals building up in the body): 1 person, 8.33%
  8. Haemoglobin Decreased: 1 person, 8.33%
  9. High Blood Cholesterol: 1 person, 8.33%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium multi-symptom relief and Lopressor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium multi-symptom relief and Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium multi-symptom relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium multi-symptom relief and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride; simethicone and metoprolol tartrate (the active ingredients of Imodium multi-symptom relief and Lopressor, respectively), and Imodium multi-symptom relief and Lopressor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: